Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.40 |
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 3/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | PDE5A | O76074 | 1/20 | 0.37 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30151511 | 0.92 | CYP4F2 (0.44) | LTA4HEPHX2TRPV3GRM5SQOR | |
| SCHEMBL24206861 | 0.92 | CYP4F2 (0.44) | LTA4HEPHX2TRPV3GRM5SQOR | |
| SCHEMBL26641259 | 0.87 | GRM5 (0.43) | TRPV3GRM5SQORCNR1PKM | |
| SCHEMBL24207230 | 0.85 | LMNA (0.47) | TRPV3GRM5SQORCNR1PKM | |
| SCHEMBL30733640 | 0.85 | GRM5 (0.40) | LTA4HEPHX2GRM5SQORCNR1 | |
| SCHEMBL24847986 | 0.83 | GSTP1 (0.47) | LTA4HEPHX2GRM5SQORGSTP1 | |
| SCHEMBL30179980 | 0.83 | GSTP1 (0.47) | LTA4HEPHX2GRM5SQORGSTP1 | |
| SCHEMBL23816219 | 0.82 | TRPV3 (0.39) | TRPV3GRM5SQORCNR1PKM | |
| SCHEMBL30064435 | 0.82 | TRPV3 (0.39) | TRPV3GRM5SQORCNR1PKM | |
| SCHEMBL24206631 | 0.81 | MAPT (0.49) | GRM5SQORCNR1PKMPDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024059808-A1 | WEE1 INHIBITORS AND METHODS FOR TREATING CANCER | RECURIUM IP HOLDINGS, LLC (US) | 2024-03-21 | — | — | WO | disclosed |